Abstract
Correction to: Nature Cardiovascular Research. Published online 8 June 2023. In the version of this article initially published, a protein (pMAPKAPK2) was misspelled in Fig. 1 and Extended Data Fig. 7; a colored box for “AKT” was missing from the second column of regulators in Fig. 5a; Extended Data Fig. 2f was missing a header above the color key; and typographical errors (extraneous citations to refs. 1, 3 and 5) were present in the “Analysis of RNA-seq data from saracatinib-treated tissue” section of Methods. In addition, the Reporting Summary and the legends for Supplementary Figs. 5 and 8 were outdated versions. The errors have been corrected in the HTML and PDF versions of the article.
| Original language | English |
|---|---|
| Pages (from-to) | 793 |
| Number of pages | 1 |
| Journal | Nature Cardiovascular Research |
| Volume | 2 |
| Issue number | 8 |
| DOIs |
|
| State | Published - Aug 2023 |
Fingerprint
Dive into the research topics of 'Publisher Correction: Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis (Nature Cardiovascular Research, (2023), 2, 6, (550-571), 10.1038/s44161-023-00278-y)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver